Resistin as a Marker of Liver Function Disorder in Combined Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

L.V. Zhuravliova, O.V. Ohnieva

Abstract


The objective of the study — to assess the correlation between resistin and indexes of the functional state of the liver in patients with non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (DM) and with their combination. Materials and methods. 110 patients were examined, among them 20 patients with NAFLD, 20 patients with DM type 2 and 70 patients with comorbidity (NAFLD + DM type 2), they were divided into 2 subgroups — 20 patients with normal body weight and 50 obese patients. The control group consisted of 20 apparently healthy individuals. Comprehensive clinical, laboratory (with determination of indicators of protein, pigment, enzyme and carbohydrate metabolism, resistin level), instrumental (ultrasound of the liver and liver biopsy (8 patients)) examinations were carried out. Results. Significant increase in plasma resistin levels in patients with comorbidity was revealed. Significant correlations between resistin levels and indicators of the functional state of the liver in these patients were established. Conclusion. In patients with NAFLD, DM type 2 and their combination, especially with concomitant obesity, there is an imbalance of fatty tissue products, a sign of which is the increase of resistin level. The relationship between resistin and indicators of the functional state of the liver mainly in the subgroup with comorbid disorders and obesity give reason to believe that hormone and metabolic disorders that affect liver function activate and worsen in obesity.


Keywords


non-alcoholic fatty liver disease; type 2 diabetes mellitus; obesity; resistin

References


Буеверов А.О. Неалкогольная жировая болезнь печени: обоснование патогенетической терапии / А.О. Буеверов, П.О. Богомолов // Клинич. персп. гастроэнтерол. и гепатол. — 2009. — № 1. — С. 3-8.

Бабак О.Я. Роль адипокинов в развитии фиброза печени при неалкогольной жировой болезни / О.Я. Бабак, Е.В. Колесникова // Сучасна гастроентерологія. — 2009. — Т. 49, № 5. — С. 5-11.

Чернявский В.В. Жировая болезнь печени как интегральная проблема внутренней медицины / В.В. Чернявский // Новости медицины и фармации. — 2011. — Т. 354, № 4. — С. 12-17.

Argentou M., Tiniakos D.G., Karanikolas M. et al. Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery / M. Argentou, D.G. Tiniakos, M. Karanikolas [et al.] // Obesity Surgery. — 2009. — Vol. 19, № 9. — Р. 1313-1323.

Bertolani C., Bataller R., Aleffi S. et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells / C. Bertolani, R. Bataller, S. Aleffi [et al.] // Am. J. Pathol. — 2006. — Vol. 169. — № 6. — Р. 204-253.

Gnacinska M., Malgorzewicz S., Lysiak-Szydlowska W., Sworczak K.. The serum profile of adipokines in overweight patients with metabolic syndrome / M. Gnacinska, S. Malgorzewicz, W. Lysiak-Szydlowska, K. Sworczak // Endokrynol. Pol. — 2010. — Vol. 61, № 1. — Р. 36-41.

Ramesh K., Shyam P., Shruti С. et al. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver diseaselndian / K. Ramesh, P. Shyam, С. Shruti [et al.] // J. Med. Res. — 2012. — Vol. 136, № 2. — Р. 229-236.

Lemoine M., Capeau J., Bastard J.P., Serfaty L. Adipokines and nonalcoholic fatty liver disease: authors’ reply / M. Lemoine, J. Capeau, J.P. Bastard, L. Serfaty // Liver Int. — 2010. — Vol. 25. — Р. 213-229.

Hivert M.F., Sullivan L.M., Fox С.S. et al. Associations of adiponectin, resistin, and tumor necrosis factor — a with insulin resistance / M.F. Hivert, L.M. Sullivan, С.S. Fox [et al.] // J. Clin. Endocrinol. Metabol. — 2008. — Vol. 93. — Р. 3165-3172.

Методи клінічних та експериментальних досліджень в медицині / За ред. І.П. Кайдашева; Л.В. Беркало, О.В. Бобович, И.О. Боброва [та ін.]. — Полтава, 2003. — 320 с.




DOI: https://doi.org/10.22141/2308-2097.3.57.2015.81526

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru